跳至主要内容
临床试验/IRCT20210817052218N1
IRCT20210817052218N1招募中3 期

Effect of milk thistle (Silymarin marianum) extract supplementation on nonalcoholic fatty liver disease in morbidly-obese patient candidates for bariatric surgery

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • patients aged between 18 and 65 years
  • morbidly-obese patients candidates for bariatric surgery , BMI above 40 kg/m2
  • Diagnosis of NAFLD in liver sonography (grades II and III steatosis) with increased levels of liver enzymes aspartate transaminase (AST) and alanine transaminase (ALT) (above 20 mg/dl for women and 30 mg/dl for men)

排除标准

  • history of alcohol consumption
  • diabetes mellitus
  • chronic liver disease
  • use of drugs such as statin, fibrate, non-steroidal anti-inflammatory drugs (NSAIDs),
  • positive results for tests of autoimmune hepatitis and virus markers (hepatitis B surface antigen, hepatitis C virus antibody)
  • unwilling to participate in study

研究者

相似试验

Milk thistle (Silymarin marianum) extract... | 临床试验